Tumor vaccine based on extracellular vesicles derived from γδ-T cells exerts dual antitumor activities.

J Extracell Vesicles · 2023 · PMC10471836 · PMID 37654012

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although γδ‐T‐EVs + free TAAs also showed a trend in the augment of tumor‐specific T cells in the presence of iDCs, its efficacy was significantly lower than γδ‐T‐EVs preloaded with TAAs (γδ‐T‐EVs (TAAs)) (Figure 2b ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.